Skip to main content
Premium Trial:

Request an Annual Quote

Tripos Announces New Agreements with Cara Therapeutics, Abbott Labs

NEW YORK, Mar. 22 (GenomeWeb News) - Informatics shop Tripos said today that its UK-based medicinal chemistry group has signed a research collaboration agreement with Cara Therapeutics, a New York-based biotech startup focused on developing therapeutics for pain and inflammation.


Separately, Tripos announced yesterday that it will collaborate with Abbott Laboratories to make compounds. The two firms will collaborate in library design, analysis and synthesis, according to a statement from the companies.


Financial details were not released for either agreement.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.